MANGALAM.NS
Mangalam Drugs & Organics Limited [MANGALAM.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MANGALAM.NS Stock Summary
Top 10 Correlated Stocks
MANGALAM.NS
In the News
MANGALAM.NS Financial details
Company Rating
-
Market Cap
1.63B
Income
-169.87M
Revenue
3.59B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
523
Optionable
No
Shortable
Yes
Earnings
13 Feb 2024
P/E
-9.92
Forward P/E
-
PEG
0.53
P/S
0.52
P/B
1.28
P/C
-
P/FCF
-
Quick Ratio
0.33
Current Ratio
1.09
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-10.73
EPS next Y
-
EPS next Q
-
EPS this Y
-93.56%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
10.57%
Revenue Q/Q
19.27%
EPS Q/Q
-113.78%
-
-
-
-
SMA20
40%
SMA50
-48.53%
SMA100
-56.25%
Inst Own
-
Inst Trans
-
ROA
-4%
ROE
-12%
ROC
-0.04%
Gross Margin
32%
Oper. Margin
-2%
Profit Margin
-5%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
90.8-132.45
52W High
-67.7%
52W Low
-52.62%
RSI
76
Rel Volume
2.63
Avg Volume
140.56K
Volume
370.27K
Perf Week
40.63%
Perf Month
60.72%
Perf Quarter
-50.67%
Perf Half Y
-50.59%
-
-
-
-
Beta
0.731
-
-
Volatility
3.6%, 5.4%
Prev Close
5%
Price
42.64
Change
5%
Company Profile
- Volume Average 140.56K
- Market Capitalization 1.63B
- Employee 523
- CEO Mr. Govardhan Murlidhar Dhoot
- Headquarters Mumbai,IN
- IPO Date 2005-05-23
-
Website
https://www.mangalamdrugs.com 
Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. The company was incorporated in 1972 and is based in Mumbai, India.
